I don't think there is necessarily a problem with the company.
I have my dislikes on the way they do things, but that's not the problem here.
We have NOT BORROWED MONEY OR DONE A RECENT SECONDARY>
END OF THE STORY.
Wallstreet is horrible. If you haven't lived in a cave in afghanistan for the last 2 years, you know they are a bunch of self serving greedy bastards who continue to operate as if we will continually bail them out. (And why not, we always have, from the days of J.p morgan in the early 1900's to now).
Analysts do their job when someone asks them to do it. I don't know this particular guy's reasoning. Maybe he works for a brokerage that has a hedge fund.
But the main thing is that we have no coverage, and we WON'T until we get around to paying up for a secondary. At that point, you will get some strong buys from GS or C or ... because they want someone to buy the stock. As it is, we only have the one dude at Brean Murray to evaluate us, and they aren't really big enough to raise awareness. HGSI has 10 analysts. All of them have a reason to upgrade it, as they recently did a secondary.
That's it. That's all. The shorts know it. They've been running their hedge funds long enough. They know if there's no coverage, and they can short it long enough, the retail investors will panic and start selling into it, further raising their profits.
The only way this ends is if a company has such success with its products that it succeeds before it needs a lot more financing. We are in that fortunate position, plus we did make a few deals that are keeping us going right now.
You can dig all day long, you are NOT going to find a problem because there is none. (Well, maybe there is, but I betcha the shorts don't know it either, and it's not the reason for the stock price.)
Let's hope the Brean Murray analyst reiterates his buy rating and his target. You can bet that that guy is going to raise his recommendation when the lupus data comes out and even further when the HPAM info comes out. But by the time Hpam is out, there might be MORE than 1 analyst. You know that IMMU is talking with some houses about the secondary, those people have analysts waiting to issue ratings.
Does anyone know what the IBD rankings for IMMU are right now? |
